Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma

In multiple myeloma, novel treatments with proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs) have prolonged survival but the disease remains incurable. At relapse, next-generation sequencing has shown occasional mutations of drug targets but has failed to identify unifying features tha...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Blood Adv
Prif Awduron: Ziccheddu, Bachisio, Biancon, Giulia, Bagnoli, Filippo, De Philippis, Chiara, Maura, Francesco, Rustad, Even H., Dugo, Matteo, Devecchi, Andrea, De Cecco, Loris, Sensi, Marialuisa, Terragna, Carolina, Martello, Marina, Bagratuni, Tina, Kastritis, Efstathios, Dimopoulos, Meletios A., Cavo, Michele, Carniti, Cristiana, Montefusco, Vittorio, Corradini, Paolo, Bolli, Niccolo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2020
Pynciau:
Lymphoid Neoplasia
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065476/
https://ncbi.nlm.nih.gov/pubmed/32126144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000779
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg